Seres Therapeutics Statistics
NASDAQ: MCRBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
2.64-0.08 (-2.94%)
Market open · Delayed 15 min · as of Oct 8, 3:33 PM ET
Seres Therapeutics by the numbers
Seres Therapeutics has a market capitalization of $26.5 million based on 10.04M shares outstanding. With trailing EPS of $-2.42, Seres Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 40.8% below its 50-day average and 67.8% below its 200-day average.
Average daily trading volume is 72.00K shares, or about $190,088 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
MCRB valuation vs. peer median
| Metric | MCRB | Peer median | Difference |
|---|---|---|---|
| Market cap | $26.52M | $28.06M | -5% |
| Avg. volume | 72.00K | 647.22K | -89% |
Peer median across 8 companies: IMMP, ABVC, CNTX, BYSI, IGC, MIRA, SHPH, RNAZ.
Valuation
- Market cap
- $26.52M
- EPS (TTM)
- $-2.42
- Shares outstanding
- 10.04M
Price and trading
- Previous close
- 2.72
- Open
- 2.68
- Day range
- 2.42 – 2.72
- 52-week range
- 2.42 – 29.98
- Beta
- —
- Volume
- 178.44K
- Average volume
- 72.00K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 26.52M
- Forward Pe
- -0.53
- Eps
- -2.42
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 29.98
- Week52 Low
- 2.42
- Avg Volume
- 72,003.00
- Shares Outstanding
- 10.04M
- Ma50
- 4.46
- Ma200
- 8.21
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -91.19%
- Pct From52w Low
- 9.09%